Chloe Aloimonos

  • Citations Per Year
Learn More
The receptor tyrosine kinase HER3 has emerged as a therapeutic target in ovarian, prostate, breast, lung, and other cancers due to its ability to potently activate the PI3K/Akt pathway, especially via dimerization with HER2, as well as for its role in mediating drug resistance. Enhanced efficacy of HER3-targeted therapeutics would therefore benefit a wide(More)
We present, ReWear, a modular 'plug-and-play' construction kit for retrofitting existing textiles (e.g., hats, scarfs, shirts) with interactive electronic and computational behaviors without sewing or the creation of code. While a range of well-designed e-textile toolkits exist (e.g., LilyPad), they cater primarily to adults and older children and present a(More)
  • 1